The global genetic testing market size was USD 13.01 Billion in 2022 and is expected to register a rapid revenue CAGR of 10.2% during the forecast period. Increasing prevalence of cancer and hereditary diseases, technological advancements, such as introduction of innovative new testing kits, rising focus on early disease detection and prevention, and decreasing cost of sequencing procedures are...

Rare Disease Genetic Testing Market, By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine and Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders (CVDs), Dermatology Disease, Others), Technology (Next-Generation Sequencing (NGS), Array Technology, PCR-based Testing, FISH, Sanger Sequencing, Karyotyping), Specialty...